Page 147 - NobleCon20-Book-Project

SeaStar Medical Holding Corporation

SELECTED FINANCIAL ITEMS ICU

(in millions of USD)
CQ4 '23 CQ1 '24 CQ2 '24 CQ3 '24 LTM
Income Statement Key Items
Total Revenue NA NA NA 0.07 0.07
Gross Profit NA NA NA 0.07 0.07
Gross Margin NM NM NM 100% 100%
EBIT (2.94) (3.95) (4.67) (4.46) (16.02)
EBIT Margin NM NM NM -6553% -23556%
Net Income to Common Shareholders (9.88) (12.70) (3.24) (4.48) (30.29)
Net Margin NM NM NM -6585% -44538%

Balance Sheet Key Items
Total Assets 3.51 7.74 3.47 4.59 4.59
Cash & Short Term Investments 0.18 5.02 1.18 2.08 2.08
% of Assets 5% 65% 34% 45% 45%
Current Assets -Total 2.31 6.54 2.41 3.62 3.62
% of Assets 66% 84% 70% 79% 79%
Total Liabilities 17.38 12.21 10.37 6.64 6.64
% of Assets 495% 158% 299% 145% 145%
Current Liabilities - Total 13.05 9.65 9.93 6.64 6.64
% of Assets 371% 125% 286% 145% 145%
Long Term Debt 4.34 2.57 NA NA NA
% of Assets 123% 33% NM NM NM
Total Equity (13.87) (4.47) (6.90) (2.05) (2.05)
% of Assets -395% -58% -199% -45% -45%

Cash Flow Statement Key Items
Net Cash Flow - Operating Activities (4.49) (3.49) (2.82) (5.00) (15.80)
Net Cash Flow - Investing NA NA NA NA 0.00
Net Cash Flow - Financing 4.59 8.33 (1.02) 5.91 17.81

Source: Capital IQ

PRICE / VOLUME

Source: Channelchek/QuoteMedia

Noble Capital Markets' Twentieth Annual Small & Microcap Investor Conference